CONTACT INFORMATIONBIOGRAPHYCREDENTIALSAWARDSCLINICAL TRIALSPUBLICATIONSAndrea C. Wasilewski, M.D.Contact InformationPhone NumbersAppointment: (585) 275-5863A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentAccepting New PatientsLocationsWilmot Cancer Institute Oncology601 Elmwood AveRochester, NY 14642-0001Oncology: (585) 275-5823Faculty AppointmentsAssistant Professor - Department of Neurology , Neuro-Oncology (SMD) Patient Care SettingNeurologyBiographyAndrea Wasilewski MD is a board certified neurologist and neuro-oncologist with a passion for providing the highest quality patient care. She is also a clinical researcher and medical educator. Dr. Wasilewski specializes in treating patients with primary brain cancer, primary central nervous system lymphoma, brain metastases and neurologic complications of cancer. Her treatment philosophy emphasizes comprehensive and multifaceted approaches to cancer care for patients and their caregivers. As a clinical researcher Dr. Wasilewski develops and studies new ways of evaluating and treating older patients with brain cancer.CredentialsSpecialtiesNeurology - General - American Board of Psychiatry and NeurologyEducation2014MD | Jagiellonian University Medical College, Faculty of MedicinePost-doctoral Training & Residency07/01/2018 - 06/30/2019Fellowship in Neuro-Oncology at University of Rochester Medical Center06/10/2014 - 6/30/2015Internship in Neurology at University of Rochester Medical Center7/1/2015 - 6/30/2018Residency in Neurology at University of Rochester Medical CenterVIEW ALL expand_moreAwards2019American Academy of Neurology Fellow ScholarshipSponsor: American Academy of NeurologyClinical TrialsA Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated GlioblastomaLead Researcher: Andrea C Wasilewski This phase II/III trial compares the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy with ipilimumab and nivolumab in treating patients with newly diagnosed MGMT unmethylated glioblastoma. Radiation therapy uses high energy photons to kill tumor and shrink tumors. Chemotherapy drugs, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Temozolomide, may not work as well for the treatment of tumors that have the unmethylated MGMT. Immunotherapy with monoclonal antibodies called immune checkpoint inhibitors, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. It is possible that immune checkpoint inhibitors may work better at time of first diagnosis as opposed to when tumor comes back. Giving radiation therapy with ipilimumab and nivolumab may lengthen the time without brain tumor returning or growing and may extend patients' life compared to usual treatment with radiation therapy and temozolomide. View Study Details Comprehensive Geriatric Assessment in Older Patients with Newly Diagnosed Malignant Gliomas Lead Researcher: Andrea C Wasilewski The purpose of this study is to collect information about the physical function, thinking, independence, social support, and medications of older patients with brain tumors in order to develop more specialized treatments and support for that population. Inclusion Criteria: Age 65 or older of any race, ethnicity, or gender; Pathologically confirmed glioblastoma or anaplastic astrocytoma; Have not started radiation or chemotherapy for brain tumor treatment View Study Details PublicationsJournal Articles9/1/2020Saleh C, Jaszczuk P, Hund-Georgiadis M, Frank S, Cordier D, Bratic Hench I, Todea A, Wasilewski A, Wilmes S, Grigioni G, Hench J. "Differentiation of rare brain tumors through unsupervised machine learning: Clinical significance of in-depth methylation and copy number profiling illustrated through an unusual case of IDH wildtype glioblastoma." Clinical neuropathology.. 2020 Sep 1; Epub 2020 Sep 01. 7/13/2020Wasilewski A, Alam A, Mohile N. "Chemotherapy toxicities and geriatric syndromes in older patients with malignant gliomas." Journal of geriatric oncology.. 2020 Jul 13; Epub 2020 Jul 13. 6/16/2020Wasilewski A, Mohile N. "Meet the expert: How I treat chemotherapy-induced peripheral neuropathy." Journal of geriatric oncology.. 2020 Jun 16; Epub 2020 Jun 16. VIEW ALL PUBLICATIONSClose WindowSchedule an appointment with Andrea C. Wasilewski, M.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. Andrea C. Wasilewski, M.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.